Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 289

1.

The CLIPMERGE PGx Program: clinical implementation of personalized medicine through electronic health records and genomics-pharmacogenomics.

Gottesman O, Scott SA, Ellis SB, Overby CL, Ludtke A, Hulot JS, Hall J, Chatani K, Myers K, Kannry JL, Bottinger EP.

Clin Pharmacol Ther. 2013 Aug;94(2):214-7. doi: 10.1038/clpt.2013.72. Epub 2013 Apr 3. No abstract available.

2.

Challenges in implementing genomic medicine: the Mayo Clinic Center for Individualized Medicine.

Farrugia G, Weinshilboum RM.

Clin Pharmacol Ther. 2013 Aug;94(2):204-6. doi: 10.1038/clpt.2013.52. Epub 2013 Mar 11. No abstract available.

3.

Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol.

Bielinski SJ, Olson JE, Pathak J, Weinshilboum RM, Wang L, Lyke KJ, Ryu E, Targonski PV, Van Norstrand MD, Hathcock MA, Takahashi PY, McCormick JB, Johnson KJ, Maschke KJ, Rohrer Vitek CR, Ellingson MS, Wieben ED, Farrugia G, Morrisette JA, Kruckeberg KJ, Bruflat JK, Peterson LM, Blommel JH, Skierka JM, Ferber MJ, Black JL, Baudhuin LM, Klee EW, Ross JL, Veldhuizen TL, Schultz CG, Caraballo PJ, Freimuth RR, Chute CG, Kullo IJ.

Mayo Clin Proc. 2014 Jan;89(1):25-33. doi: 10.1016/j.mayocp.2013.10.021.

4.

Electronic Medical Record-Integrated Pharmacogenomics and Related Clinical Decision Support Concepts.

Caraballo PJ, Bielinski SJ, St Sauver JL, Weinshilboum RM.

Clin Pharmacol Ther. 2017 Aug;102(2):254-264. doi: 10.1002/cpt.707. Epub 2017 May 26. Review.

PMID:
28390138
6.

Feasibility of incorporating genomic knowledge into electronic medical records for pharmacogenomic clinical decision support.

Overby CL, Tarczy-Hornoch P, Hoath JI, Kalet IJ, Veenstra DL.

BMC Bioinformatics. 2010 Oct 28;11 Suppl 9:S10. doi: 10.1186/1471-2105-11-S9-S10.

7.

Genetic variation among 82 pharmacogenes: The PGRNseq data from the eMERGE network.

Bush WS, Crosslin DR, Owusu-Obeng A, Wallace J, Almoguera B, Basford MA, Bielinski SJ, Carrell DS, Connolly JJ, Crawford D, Doheny KF, Gallego CJ, Gordon AS, Keating B, Kirby J, Kitchner T, Manzi S, Mejia AR, Pan V, Perry CL, Peterson JF, Prows CA, Ralston J, Scott SA, Scrol A, Smith M, Stallings SC, Veldhuizen T, Wolf W, Volpi S, Wiley K, Li R, Manolio T, Bottinger E, Brilliant MH, Carey D, Chisholm RL, Chute CG, Haines JL, Hakonarson H, Harley JB, Holm IA, Kullo IJ, Jarvik GP, Larson EB, McCarty CA, Williams MS, Denny JC, Rasmussen-Torvik LJ, Roden DM, Ritchie MD.

Clin Pharmacol Ther. 2016 Aug;100(2):160-9. doi: 10.1002/cpt.350. Epub 2016 Jun 1.

8.
9.

Technical desiderata for the integration of genomic data with clinical decision support.

Welch BM, Eilbeck K, Del Fiol G, Meyer LJ, Kawamoto K.

J Biomed Inform. 2014 Oct;51:3-7. doi: 10.1016/j.jbi.2014.05.014. Epub 2014 Jun 12.

10.

Lessons Learned When Introducing Pharmacogenomic Panel Testing into Clinical Practice.

Rosenman MB, Decker B, Levy KD, Holmes AM, Pratt VM, Eadon MT.

Value Health. 2017 Jan;20(1):54-59. doi: 10.1016/j.jval.2016.08.727. Epub 2016 Oct 21.

PMID:
28212969
11.

Integration of Genomics in Primary Care.

Larson EA, Wilke RA.

Am J Med. 2015 Nov;128(11):1251.e1-5. doi: 10.1016/j.amjmed.2015.05.011. Epub 2015 May 30. Review.

PMID:
26031886
12.
13.

Making pharmacogenomic-based prescribing alerts more effective: A scenario-based pilot study with physicians.

Overby CL, Devine EB, Abernethy N, McCune JS, Tarczy-Hornoch P.

J Biomed Inform. 2015 Jun;55:249-59. doi: 10.1016/j.jbi.2015.04.011. Epub 2015 May 7.

14.

Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems.

Rasmussen-Torvik LJ, Stallings SC, Gordon AS, Almoguera B, Basford MA, Bielinski SJ, Brautbar A, Brilliant MH, Carrell DS, Connolly JJ, Crosslin DR, Doheny KF, Gallego CJ, Gottesman O, Kim DS, Leppig KA, Li R, Lin S, Manzi S, Mejia AR, Pacheco JA, Pan V, Pathak J, Perry CL, Peterson JF, Prows CA, Ralston J, Rasmussen LV, Ritchie MD, Sadhasivam S, Scott SA, Smith M, Vega A, Vinks AA, Volpi S, Wolf WA, Bottinger E, Chisholm RL, Chute CG, Haines JL, Harley JB, Keating B, Holm IA, Kullo IJ, Jarvik GP, Larson EB, Manolio T, McCarty CA, Nickerson DA, Scherer SE, Williams MS, Roden DM, Denny JC.

Clin Pharmacol Ther. 2014 Oct;96(4):482-9. doi: 10.1038/clpt.2014.137. Epub 2014 Jun 24.

15.

Integrated Database And Knowledge Base For Genomic Prospective Cohort Study In Tohoku Medical Megabank Toward Personalized Prevention And Medicine.

Ogishima S, Takai T, Shimokawa K, Nagaie S, Tanaka H, Nakaya J.

Stud Health Technol Inform. 2015;216:1057.

PMID:
26262356
16.

Navigating pleiotropy in precision medicine: pharmacogenes from trauma to behavioral health.

Oberg V, Differding J, Fisher M, Hines L, Wilke RA.

Pharmacogenomics. 2016 Apr;17(5):499-505. doi: 10.2217/pgs.16.6. Epub 2016 Mar 29. Review.

PMID:
27023676
17.

Role of genomics on the path to personalized medicine.

Tremblay J, Hamet P.

Metabolism. 2013 Jan;62 Suppl 1:S2-5. doi: 10.1016/j.metabol.2012.08.023. Epub 2012 Sep 25.

PMID:
23021037
18.

Institutional profile: University of Florida and Shands Hospital Personalized Medicine Program: clinical implementation of pharmacogenetics.

Johnson JA, Elsey AR, Clare-Salzler MJ, Nessl D, Conlon M, Nelson DR.

Pharmacogenomics. 2013 May;14(7):723-6. doi: 10.2217/pgs.13.59. No abstract available.

19.

Implementing Genomic Clinical Decision Support for Drug-Based Precision Medicine.

Freimuth RR, Formea CM, Hoffman JM, Matey E, Peterson JF, Boyce RD.

CPT Pharmacometrics Syst Pharmacol. 2017 Mar;6(3):153-155. doi: 10.1002/psp4.12173. Review.

20.

Prerequisites to implementing a pharmacogenomics program in a large health-care system.

Levy KD, Decker BS, Carpenter JS, Flockhart DA, Dexter PR, Desta Z, Skaar TC.

Clin Pharmacol Ther. 2014 Sep;96(3):307-9. doi: 10.1038/clpt.2014.101. Epub 2014 May 7.

Supplemental Content

Support Center